AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Compare how robo advisor fees stack up against potential returns to help you decide if automation fits your investing plan. This intro explains the core cost-benefit idea in plain terms.
22,067 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Constellation Energy has moved from a traditional utility to a player tied to data-center power and AI demand. This a...
Mega-cap AI bets are fueling a surge in debt issuance this year, prompting fresh debate over whether the AI expansion...
What’s going with stock? AMD is riding a data center and AI wave. This guide breaks down the drivers, risks, and real...
Jamie Dimon's JPMorgan Chase just delivered a striking quarterly message: big gains in equities trading and a higher ...
The IEA just revised demand down by 420,000 barrels per day, signaling slower consumption ahead. This shift could res...
Momentum can tilt a portfolio toward recent winners. This article explains how two Vanguard ETFs using momentum aim t...
As the Dow marks its 130th birthday, savvy investors look for steady income and durable growth. Here are three blue c...
When a big insurer surprises with profit growth as tech stocks stumble, the market takes notice. This piece breaks do...
As households cross a $3 million nest egg, financial planners urge careful review of life-insurance needs. The debate...
AI-driven demand is reshaping chip markets, but selecting the right names matters. This guide highlights five semicon...
Electricity demand is rising fast, and this shifts the playing field for energy stocks. Learn how to identify what be...